Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results From DARENCA Study 2

European Urology - Netherlands
doi 10.1016/j.eururo.2014.12.017
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Elsevier BV

Related search

Molecular Subtyping of Metastatic Renal Cell Carcinoma: Implications for Targeted Therapy

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2014English

Targeted Therapy for Renal Cell Carcinoma

2011English

Efficacy of Targeted Therapy for Metastatic Renal Cell Carcinoma in the Elderly Patient Population

Clinical Genitourinary Cancer
OncologyUrology
2014English

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy in the United States: A SEER Analysis

World Journal of Urology
Urology
2012English

Bevacizumab Monotherapy as Salvage Therapy for Advanced Clear Cell Renal Cell Carcinoma Pretreated With Targeted Drugs

Clinical Genitourinary Cancer
OncologyUrology
2016English

Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Targeted Therapy After Immuno-Oncology Checkpoint Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Long-Term Response to Sunitinib Therapy for Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2013English

Clinical Impact of Targeted Therapies in Patients With Metastatic Clear-Cell Renal Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2014English

Metastatic Polyp of the Gallbladder From Renal Cell Carcinoma

HPB
HepatologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy